• 咨询热线
    客服服务热线 13671568941/15317326293
  • 在线咨询
  • 微信客服
    微信客服
  • 公众号
    扫码关注公众号

Neferine

CAS No. 2292-16-2

Neferine ( (-)-Neferine )

产品货号. M18271 CAS No. 2292-16-2

莲心碱具有抗肿瘤活性,CYP3A4 介导的代谢激活和 GSH 消耗增强了莲心碱诱导的细胞毒性。

纯度: >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
规格 价格/人民币 库存 数量
5MG ¥430 有现货
10MG ¥622 有现货
25MG ¥1004 有现货
50MG ¥1516 有现货
100MG ¥2178 有现货
500MG 获取报价 有现货
1G 获取报价 有现货
1 mL x 10 mM in DMSO ¥594 有现货

生物学信息

  • 产品名称
    Neferine
  • 注意事项
    本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
  • 产品简述
    莲心碱具有抗肿瘤活性,CYP3A4 介导的代谢激活和 GSH 消耗增强了莲心碱诱导的细胞毒性。
  • 产品描述
    Neferine has anti-tumor activities , Metabolic activation mediated by CYP3A4 and GSH depletion enhanced Neferine-induced cytotoxicity. Neferine can be helpful to increase the efficacy of DOX and to achieve anticancer synergism by curbing the toxicity. Neferine inhibited high glucose-induced endothelial apoptosis via blocking ROS/Akt/NF-κB pathway, which provides the evidence for using Neferine to treat diabetic vasculopathy. Neferine induced apoptosis in a dose-dependent manner with the hypergeneration of reactive oxygen species, activation of MAPKs, lipid peroxidation, depletion of cellular antioxidant pool, loss of mitochondrial membrane potential, and intracellular calcium accumulation.
  • 体外实验
    Neferine down regulates hypoxia induced NF-κB p65 nuclear translocation and COX-2 expressions. Neferine reduces high-glucose-induced collagen production and inhibits TGF-β1-Smad, ERK and p38 MAPK signaling activation in cardiac fibroblasts. Cardiac fibroblasts (CFs) are cultured in HG medium with varying concentrations of Neferine (1, 2, or 5 μM). CCK-8 assays are carried out at different time points (24, 48, and 72 h). Compared with normal glucose (NG) and osmotic control (OC) treatments, High glucose (30 mM) treatment significantly increases the proliferation of CFs in a time-dependent manner (P<0.05). High glucose (HG)-induced CF proliferation is markedly attenuated by Neferine treatment at either 2 or 5 μM compared with vehicle treatment. However, 1 μM Neferine does not inhibit HG-induced proliferation of CFs. Therefore, 2 and 5 μM Neferine are used in the remaining experiments.
  • 体内实验
    Neferine treatment at both low-dose (60 mg/kg/day by gavage) and high-dose (120 mg/kg/day by gavage) reduces the increment of collagen I, III and TGF-β1 protein expression induced by hyperglycemia.
  • 同义词
    (-)-Neferine
  • 通路
    Neuroscience
  • 靶点
    GluR
  • 受体
    Others
  • 研究领域
    Others-Field
  • 适应症
    ——

化学信息

  • CAS Number
    2292-16-2
  • 分子量
    624.77
  • 分子式
    C38H44N2O6
  • 纯度
    >98% (HPLC)
  • 溶解度
    DMSO : 62 mg/mL 99.24 mM;
  • SMILES
    CN1CCC2=CC(=C(C=C2C1CC3=CC=C(C=C3)OC)OC4=C(C=CC(=C4)CC5C6=CC(=C(C=C6CCN5C)OC)OC)O)OC
  • 化学全称
    ——

运输与储存

  • 储存条件
    (-20℃)
  • 运输条件
    With Ice Pack
  • 稳定性
    ≥ 2 years

参考文献

产品手册
关联产品
  • BMT-145027

    BMT-145027 是一种 mGluR5 正变构调节剂,不具有固有的激动剂活性 (EC50 = 47 nM)。

  • TC-N 22A

    TC-N 22A 是一种强效的、选择性的、口服活性的、可以通透血脑的 mGlu4 正向别构调节剂 (PAM),在表达人 mGlu4 的 BHK 细胞中 EC50 为 9 nM。TC-N 22A 在激动和正向别构模型中,对 mGlu 1、2、3、5 和 7 受体的活性很小 (EC50 >10 μM)。TC-N 22A 可以用于中枢神经系统疾病研究的潜力。

  • GW791343 3HCl

    GW791343 HCl是GW791343的HCl盐形式,GW791343是人P2X7受体抑制剂的非竞争性变构调节剂,pIC50为7。